Niagen Bioscience Inc stock is traded at $2.11, with a volume of 1,303,666. It is down -16.47% in the last 24 hours and down -21.46% over the past month. Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Previous Close:
$2.52
Open:
$2.32
24h Volume:
1,303,666
Relative Volume:
2.27
Market Cap:
$166.56M
Revenue:
$130.42M
Net Income/Loss:
$18.64M
P/E Ratio:
9.65
EPS:
$0.2182
Net Cash Flow:
$4.05M
1W Performance:
-15.80%
1M Performance:
-21.46%
6M Performance:
-56.33%
1Y Performance:
-69.40%
1-Day Range:
$2.05$2.34
1-Week Range:
$2.05$2.59
52-Week Range:
$2.05$7.95
Niagen Bioscience Inc Stock (NAGE) Company Profile
Name
Niagen Bioscience IncSector
Consumer DefensiveIndustry
Packaged FoodsPhone
310-388-6706Address
10900 WILSHIRE BLVD, LOS ANGELES, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS